期刊文献+

前列腺移行带腺体定量分析

Quantitative analysis of the acinar components in prostatic transition zone
原文传递
导出
摘要 目的通过定量分析良性前列腺增生(BPH)患者前列腺和成人正常前列腺移行带腺体各成分含量及相关组织学形态的变化,探讨良性前列腺增生症治疗方案的选择。方法用计算机图像分析系统对经HE染色的40例良性前列腺增生症患者手术切除的前列腺和10例成人正常前列腺移行带组织标本进行形态学定量分析,分别测定腺体、腺腔、上皮的平均面积及上皮细胞高度。结果(1)正常前列腺和BPH前列腺移行带上皮细胞高度分别为(24.87±4.53)μm和(19.06±5.49)μm(P<0.001)。(2)正常前列腺和BPH前列腺移行带腺体、上皮、腺腔的平均面积分别为(0.087±0.028)mm2和(0.062±0.030)mm2(P<0.01)、(0.042±0.016)mm2和(0.027±0.013)mm2(P<0.01)、(0.045±0.018)mm2和(0.035±0.021)mm2(P>0.05)。结论BPH前列腺组织主要以基质成分增生为主;BPH的治疗应以α受体阻滞剂和手术治疗为主。 Objective To evaluate quantitatively the acinar components and relative morphological changes of the transition zone in various prostates, Methods The quantitative morphometry of forty BPH specimens obtained from suprapubic transvesical prostatectomy and ten normal prostatic specimens was performed with computer-assisted image analysis system, and all samples were stained with haematoxylin and eosin (HE). The mean epithelial heights and the average areas of acini, lumens and epithelial cells were quantitated respectively. Results 1, The epithelial heights of adult normal prostate and hyperplastic prostate were (24.87±4.53) μm and (19.06±5.49) μm (P〈0.001). 2. The average areas of acinus, epithelium and lumen of the normal control transition zone tissue and BPH group were (0.087±0.028)mm^2 and (0.062±0.030)mm^2(P〈0.01), (0.042±0.016)mm^2 and (0.027±0.013)mm^2 (P〈0.01), (0.045±0.018)mm^2 and (0.035±0.021) mm^2 (P〈0.05), respectively. Conclusion Stroma is the most proliferative component in the prostatic tissue of BPH, Alpha receptor blockade and surgical therapy should be considered firstly in treatment of BPH.
出处 《中国男科学杂志》 CAS CSCD 2006年第1期25-27,共3页 Chinese Journal of Andrology
关键词 前列腺 前列腺增生 图像处理 计算机辅助 prostate prostatic hyperplasia image processing, computer-assisted
  • 相关文献

参考文献12

  • 1Chagas MA, Babinski MA, Costa WS, et al. Stromal and acinar components of the transition zone in normal and hyperplastic human prostate. BJU Int 2002; 89(7): 699-702. 被引量:1
  • 2Thorpe A, Neal D, Benign prostatic hyperplasia. Lancet 2003; 361(9366): 1359-1365. 被引量:1
  • 3Catalona WJ, Ramos CG, Carvalhal GF, et al. Lowering PSA cutoffs to enhance detection of curable prostate cancer. Urology 2000; 55(6): 791-795. 被引量:1
  • 4Krumholtz JS, Carvalhal GF, Ramos CG, et al. Prostate-specific antigen cutoff of 2.6ng/ml for prostate cancer screening is associated with favorable pathologic tumor features. Urology 2002; 60(3): 473-474. 被引量:1
  • 5McNeal JE. Prostate. In: Sterenberg SS. Histology for pathologists. 2^nd ed. Philadelphia: Lippincott Raven,1997:997-1017. 被引量:1
  • 6Roehrobom CG, McConnell JD. Etiology, pathophysiology,epidemiology, and natural history of benign prostatic hyperplasia. In: Walsh PC, Retic AB, Vaughan ED, et al.eds. Campbell's urology. Vol 2.8^th ed. Philadelphia:Saunders, 2002:1297-1307. 被引量:1
  • 7陈辉熔,邓春华,丘少鹏,刘建中,郑克立.良性前列腺增生病人前列腺基质成分含量的变化[J].中华男科学杂志,2001,7(6):362-364. 被引量:8
  • 8夏同礼,邓方明,杨建茹,何其华,顾方六,郭应禄.国人正常前列腺组织成分定量分析[J].中华泌尿外科杂志,1995,16(6):345-347. 被引量:22
  • 9Narayan P, Pateli M, Rice L, et al. Histopathology of benign prostatic hyperplasia. In: Narayan P ed. Benign prostatic hyperplasia. London: Churchill Livingstone;2000:19-22. 被引量:1
  • 10Cohen RJ, McNeal JE, Redmond SL, et al. Luminal contents of benign and malignant prostatic glands: Correspondence to altered secretory mechanisms. Hum Pathol 2000; 31(1): 94-100. 被引量:1

二级参考文献5

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部